Molecular architecture of leishmania EF-1α reveals a novel site that may modulate protein translation: A possible target for drug development
Authors:
- Artem CherkasovACArtem Cherkasov
- Devki NandanDNDevki Nandan
- 1 May 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 356 (4) , 886-892
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (FRN-38005)
This publication has 16 references indexed in Scilit:
- Molecular cloning, biochemical and structural analysis of elongation factor-1α from Leishmania donovani: comparison with the mammalian homologueBiochemical and Biophysical Research Communications, 2003
- Leishmania EF-1α Activates the Src Homology 2 Domain Containing Tyrosine Phosphatase SHP-1 Leading to Macrophage DeactivationJournal of Biological Chemistry, 2002
- Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasisEuropean Journal of Immunology, 2001
- Elongation Factor-1α Is a Novel Substrate of Rho-Associated KinaseBiochemical and Biophysical Research Communications, 2000
- In vitro translation in a cell‐free system from Trypanosoma brucei yields glycosylated and glycosylphosphatidylinositol‐anchored proteinsEuropean Journal of Biochemistry, 1999
- Eukaryotic Translation Elongation Factor 1α: Structure, Expression, Functions, and Possible Role in Aminoacyl-tRNA Channeling1998
- Interleukin‐10 and interleukin‐4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generationEuropean Journal of Immunology, 1997
- Bundling of actin filaments by elongation factor 1 alpha inhibits polymerization at filament ends.Journal of Cell Biology, 1996
- Intracellular Survival of Protozoan Parasites with Special Reference to Leishmania spp., Toxoplasma gondil and Trypanosoma cruzi1996
- Elongation factor 1α, translation and the cytoskeletonTrends in Biochemical Sciences, 1995